Navigation Links
Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board
Date:4/30/2009

Milledge brings proven experience, dynamic insights and strategic focus to neurovascular interventions developer.

PALO ALTO, Calif., April 30 /PRNewswire/ -- Nfocus Neuromedical Inc. announced today that its directors elected Eric P. Milledge as Chairman of the Board. "Mr. Milledge brings exceptional industry experience, business acumen and leadership to Nfocus, as we advance our pursuit of break-through technologies in the dynamic field of endovascular neurosurgery," noted President and CEO Martin S. Dieck.

"The relevance of Milledge's 34 years of experience with Johnson & Johnson is what attracted us to him. Most recently serving as Company Group Chairman for the LifeScan division of Johnson & Johnson and as a member of the J&J Medical Devices & Diagnostics Group Operating Committee, Milledge will prove invaluable in strategically guiding us through our development, regulatory approval and commercialization process."

"Neurovascular disease is one of the leading causes of death and disability and is still widely underserved. I am impressed with the potential of the technological advances Nfocus brings to this medical field," said Milledge. "It is an honor and a privilege to work with the Nfocus team in bringing surgeons simpler, less invasive devices that could change the lives of millions through improved endovascular surgery outcomes."

Milledge began with J&J in 1973. He later held positions of Company Group Chairman of Johnson & Johnson Health Care Systems, Inc., President of Ortho-McNeil, and President of Ortho Pharmaceutical Corporation.

"Nfocus has its hand on the pulse of the dynamic developments in the emerging endovascular neurosurgery field," added Milledge. "It's an exciting time to add strategic guidance, which can further the advancement of our product technologies."

Abo
'/>"/>

SOURCE Nfocus Neuromedical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
2. Nfocus Neuromedical Announces Acquisition of StarFire Medical
3. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
4. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
5. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
6. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
7. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
8. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
9. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
10. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
11. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... California (PRWEB) March 06, 2015 ... one of the most common forms of cancer and ... Breast cancer can be screened through various techniques and ... Mammography however remains the gold standard technique in breast ... as cost, time taken for the procedure, required expertise ...
(Date:3/6/2015)... York, NY (PRWEB) March 06, 2015 Ticket ... tickets . This popular ticket exchange has extended their customer ... hails from Hebden Bridge, West Yorkshire England and he began ... 2005. In the past couple of years Ed Sheeran ... though whenever Ed Sheeran is on stage he is having ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Further solidifying ... , Medical Doctor Associates announced today that the company ... after winning the Best of Staffing Talent Award five ... Inavero’s Best of Staffing Talent Diamond winners are proven ... given to them by the individuals they have helped ...
(Date:3/6/2015)... TN (PRWEB) March 06, 2015 Since ... January 1, 2015, there has been an overwhelming demand ... an efficient and compliant CCM program. The Centers ... on several matters. , PYA’s updated white paper—“ ... this new guidance into a detailed, yet practical “how ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Magellan Rx ... only comprehensive source for key trends and statistics on ... medical injectables. Executives from Magellan Rx Management will discuss ... Report: Discover Your Hidden Specialty Drug Spend,” a complimentary ... Services, Inc. , Specialty drug spend makes up more ...
Breaking Medicine News(10 mins):Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2
... available in German . , Scientists from the ... lived off more than 100 million years ago. They want to ... as they did. In actual fact such gigantic animals should not ... in the journal ,Proceedings of the Royal Society B,. , Take ...
... & Melinda Gates Foundation to ... in 11 new countries, OAK BROOK, Ill., Feb. 6 ... it has received a $24.2 million grant from the Bill ... Micro Insurance Agency, greatly expand its insurance,products to the poor ...
... allayed some panic about suspected cancer-causing agents, such as ... has been developed through the Cancer Control Program at ... University of New South Wales (UNSW) researcher, Professor Bernard ... level of risk is high say, on a ...
... Feb. 6 Parental Alienation Awareness,Organization (PAAO) is beginning ... for April 25th - Parental Alienation Awareness Day., ... until they,experience it, parental alienation awareness was put forth ... The mission of PAAO is to help the ...
... PALO ALTO, Calif., Feb. 6 Jazz,Pharmaceuticals, Inc. (Nasdaq: ... fourth quarter and full year 2007 financial results on ... financial markets. Jazz,Pharmaceuticals will host an investor conference call ... updates on February 13, 2008, at,5:00 p.m. Eastern Time/2:00 ...
... The Female Health Company,(Amex: FHC ) today announced ... the Premarket Approval Application (PMA) it submitted for,its second ... The Center for Devices and Radiological Health (CDRH) received,FHC,s ... Health Company, Inc., The Female Health Company, based ...
Cached Medicine News:Health News:Bonn scientists simulate dinosaur digestion in the lab 2Health News:Bonn scientists simulate dinosaur digestion in the lab 3Health News:Opportunity International's Micro Insurance Agency to Develop and Provide Life, Health and Crop Insurance for 21 Million Poor People 2Health News:Opportunity International's Micro Insurance Agency to Develop and Provide Life, Health and Crop Insurance for 21 Million Poor People 3Health News:Opportunity International's Micro Insurance Agency to Develop and Provide Life, Health and Crop Insurance for 21 Million Poor People 4Health News:Opportunity International's Micro Insurance Agency to Develop and Provide Life, Health and Crop Insurance for 21 Million Poor People 5Health News:Reducing cancer panic 2Health News:Parental Alienation Awareness Organization Begins Preparations for Parental Alienation Awareness Day - April 25th 2Health News:Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008 2Health News:The Female Health Company Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application 2
(Date:3/5/2015)... 5, 2015  IRIDEX Corporation (Nasdaq: IRIX ) ... ended January 3, 2015.  , Revenues were $11.8 ... the Company and up 11% from $10.6 million in the ... a record, up 12% from $38.3 million in 2013. ... up from 48.6% in the fourth quarter of the prior ...
(Date:3/5/2015)... 5, 2015  As the pharmaceutical industry works ... & Compliance professionals are placing a significant emphasis ... issued today by LRN, the leader in Ethics ... majority of respondents expressed that clarity on company ... of E&C training programs (57%), trumping understanding of ...
(Date:3/5/2015)... FALLS, N.J. , March 5, 2015 CANTEL ... results for its second quarter ended January 31, 2015 on ... conference call to discuss the results at 11:00 AM ET. ... (877) 407-8033 approximately 5 to 10 minutes before the beginning ... digital replay of the call will be available from Thursday, ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
... tumors (NET) experienced,clinical benefit when treated with daily RAD001 and monthly Sandostatin LAR ... Depot, - 77% of patients with pancreatic NET ... treated with daily RAD001, - Data show RAD001, an ... have limited ...
... Sept. 12 InVitria,( http://www.InVitria.com ), a ... enhance productivity, safety and time to market ... science research and,diagnostics industry, will be an ... and Exhibition in Anaheim, California on September,23-26. ...
Cached Medicine Technology:RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 2RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 3RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 4RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 5RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 6RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 7InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International 2
... The new, hydrophilic PressureWire Certus ... the latest innovative cardiology tool for ... multivessel disease using Fractional Flow Reserve ... torquability and pushability with a strengthened ...
... The Sound Pro Combination ... table solution, combining the ... the Ultra Pro and ... ideal for OB/GYN, general ...
...
... mecA ASR contains primers and a FAM-labeled probe ... region of the mecA gene. In addition, this ... DNA for an internal control sequence. This ASR ... Texas Red reporter dyes such as the Cepheid ...
Medicine Products: